Trexquant Investment LP Vaxcyte, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$46.0 - $53.1 $1.75 Million - $2.02 Million	38,058 Added 722.03%	43,329 $2.21 Million
Q2 2023 Aug 11, 2023	SELL	$34.66 - $54.07 $1.17 Million - $1.83 Million	-33,893 Reduced 86.54%	5,271 $263,000
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $818,214 - $1.06 Million	22,559 Added 135.86%	39,164 $1.47 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $341,730 - $796,209	16,605 New	16,605 $796,000
Q2 2022 Aug 11, 2022	BUY	$17.68 - $26.58 $297,925 - $447,899	16,851 New	16,851 $367,000

290

110M

248K

109K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $6.26B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.